Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success.

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

New narcolepsy treatments are being tested in the clinic, and recently, some of them have made promising strides. How far ...

Learn how Deep Science Ventures’ zero-data approach tackles biotech’s early funding challenges to speed innovation and reduce ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and gene therapy.

XOMA Royalty’s acquisition of Turnstone Biologics highlights how royalty deals can revive biopharma companies and drive industry innovation.

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better.

The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US scientific talent.